Рет қаралды 122
Michael Lidsky, MD, Associate Professor of Surgery at Duke Health, and Cathy Eng, MD, FACP, FASCO, David H. Johnson Endowed Chair of Surgical and Medical Oncology at Vanderbilt-Ingram Cancer Center, discus the PUMP trial - an open phase 3 comparison of hepatic arterial infusion in addition to standard-of-care chemotherapy versus standard-of-care chemotherapy alone in treating patients with colorectal cancer and unresectable liver metastases.